Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis for Very Low Birth Weight Infants -Multi-Center Randomized Control Trial

NCT00540033 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT00540033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00540033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis for Very Low Birth Weight Infants -Multi-Center Randomized Control Trial
Lead sponsor
China Medical University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2005
Completion date
June 30, 2007
Enrollment
217 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enterocolitis, necrotizing